Research and development of medical products: opportunities and challenges

In October 2010, the Academy's FORUM held a roundtable focusing on research and development of medical products and the importance of regulatory science to the healthcare portfolio.

Status: Completed

Reforms to NHS workforce education and training

In 2011, the Academy worked to ensure that NHS reforms generated an education and training system that enables the NHS to nurture future research leaders.

Status:

Academy response to Government life sciences commitments

Academy response to Government life sciences commitments in 2011 and 2012

Status: Completed

Team science

This report, published in March 2016, examined the current incentives and disincentives for individual researchers participating in ‘team science’, and how to improve reward and recognition for their contributions. 

Status: Completed

Future of the Human Fertilisation and Embryology Authority and the Human Tissue Authority

Status:

Public Health England and research

The Academy worked with Public Health England to ensure that the new public health structures in England are underpinned and evaluated by a sound evidence base

Status:

Public health research: reflections from the CDC

In 2012, the Academy held a roundtable discussion on strengthening research in public health with Dr Tom Frieden, Director of the US Centers for Disease Control and Prevention (CDC) and previously Commissioner of the New York City Health Department.

Status:

Impact of the EU Clinical Trials Directive 2001/20/EC

Status: Completed

Care Bill

The Academy welcomes the news that the Care Bill has received Royal Assent and become an Act of Parliament.

Status: Completed

Meeting with Dr John Landers, ASC Chair

A meeting with Dr John Landers, ASC Chair

Status: Completed